Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316589
Status:
COMPLETED
Last Update Posted:
2019-01-03
First Post:
2006-04-19
Brief Title:
Safety and Immunogenicity of IMVAMUNE MVA-BN Smallpox Vaccine in HIV Infected Patients
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic
Organization Data
Organization:
Bavarian Nordic
Class:
INDUSTRY
Study ID:
POX-MVA-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bavarian Nordic
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Institutes of Health NIH | NIH |